Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SECURITY NATIONAL FINANCIAL CORPSNFCA · Entity 6207 | Director | October 01, 2026 | October 05, 2026 |
| USANA HEALTH SCIENCES INCUSNA · Entity 6114 | Director | July 23, 2026 | July 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SECURITY NATIONAL FINANCIAL CORP
Report date October 01, 2026 · Filed October 05, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 34,187 |
Reported balance
After 2026-10-01 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-10-01 · Exercise / conversion · Acquired 615 · Balance 34,187 F1: Adjusted for the annual 5% stock dividend paid on July 14, 2026. |
| Class A Common StockSEC Table I · non-derivative | Direct | 33,572 |
Reported balance
After 2026-10-01 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2026-10-01 · Disposition to issuer · Disposed 615 · Balance 33,572 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $8.53 · Expires 2026-12-31 | Direct | 1,230 |
Reported balance
After 2025-12-05 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2025-12-05 · Grant · Acquired 1,230 · Balance 1,230 F2: These restricted stock units were granted on December 5, 2025 for 2,461 shares of Class A Common Stock under the 2022 Equity Incentive Plan at a price of $8.53 per share. The units granted vest quarterly, and will be fully vested on December 31, 2026. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $8.53 · Expires 2026-12-31 | Direct | 615 |
Reported balance
After 2026-07-01 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2026-07-01 · Grant · Disposed 615 · Balance 615 F2: These restricted stock units were granted on December 5, 2025 for 2,461 shares of Class A Common Stock under the 2022 Equity Incentive Plan at a price of $8.53 per share. The units granted vest quarterly, and will be fully vested on December 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Adjusted for the annual 5% stock dividend paid on July 14, 2026.
F2: These restricted stock units were granted on December 5, 2025 for 2,461 shares of Class A Common Stock under the 2022 Equity Incentive Plan at a price of $8.53 per share. The units granted vest quarterly, and will be fully vested on December 31, 2026.
USANA HEALTH SCIENCES INC
Report date July 23, 2026 · Filed July 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,632 |
Reported balance
After 2026-07-23 transaction · row 1
1 source rowRow 1 · 2026-07-23 · Exercise / conversion · Acquired 1,632 · Balance 1,632 F1: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,895 |
Reported balance
After 2026-07-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-23 · Exercise / conversion · Disposed 1,632 · Balance 4,895 F1: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2: Restricted Stock Units vest 25% on July 23, 2026, October 22, 2026, January 21, 2027, and April 22, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2: Restricted Stock Units vest 25% on July 23, 2026, October 22, 2026, January 21, 2027, and April 22, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2022 Filed Aug 1, 2022 17:08 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 404 | $70.00 | $28,280.00 |
DisclosureSEC source: 0001415889-22-008051 · form4-08012022_100804.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 17:41 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 404 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007993 · form4-07272022_100730.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,212 Underlying: Common Stock · 404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units Vest 25% on July 25, 2022, October 25,2022, January 25, 2023 and April 25, 2023. F2 · derivative.expiration_date: Restricted Stock Units Vest 25% on July 25, 2022, October 25,2022, January 25, 2023 and April 25, 2023. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 17:41 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 404 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007993 · form4-07272022_100730.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:46 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 312 | $68.25 | $21,294.00 |
DisclosureSEC source: 0001415889-22-005564 · form4-05232022_050508.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| April 27, 2022 Filed Apr 28, 2022 01:41 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004295 · form4-04272022_060436.xml · derivative · entry 3 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,616 Underlying: Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 25% on July 28,2021, October 17, 2021, February 9, 2021, and April 27, 2022. F3 · derivative.expiration_date: Restricted Stock Units vest 25% on July 28,2021, October 17, 2021, February 9, 2021, and April 27, 2022. Read SEC document |
| April 27, 2022 Filed Apr 28, 2022 01:41 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004295 · form4-04272022_060436.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| April 25, 2022 Filed Apr 28, 2022 01:41 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 1,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004295 · form4-04272022_060436.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,928 Underlying: Common Stock · 1,616 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units Vest 25% on July 25, 2022, October 25,2022, January 25, 2023 and April 25, 2023. F2 · derivative.expiration_date: Restricted Stock Units Vest 25% on July 25, 2022, October 25,2022, January 25, 2023 and April 25, 2023. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 23:11 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 312 | $89.62 | $27,962.19 |
DisclosureSEC source: 0001179110-22-001339 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 20:47 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Unit · Derivative | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001090 · edgar.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312 Underlying: Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 20:47 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-001090 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| December 03, 2021 Filed Jan 28, 2022 21:43 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $8.62 Strike: $8.62 | $51,720.00 |
DisclosureSEC source: 0001493152-22-002561 · ownership.xml · derivative · entry 13 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Class A Common Stock · 6,000 shares Expires 2031-12-03 F13 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share. The option vests in four equal quarterly installments of Class A Common Stock, beginning on June 27, 2020, until such shares are fully vested; 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · shares: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share. The option vests in four equal quarterly installments of Class A Common Stock, beginning on June 27, 2020, until such shares are fully vested; 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share. The option vests in four equal quarterly installments of Class A Common Stock, beginning on June 27, 2020, until such shares are fully vested; 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · derivative.exercise_date: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share. The option vests in four equal quarterly installments of Class A Common Stock, beginning on June 27, 2020, until such shares are fully vested; 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · derivative.underlying_shares: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share. The option vests in four equal quarterly installments of Class A Common Stock, beginning on June 27, 2020, until such shares are fully vested; 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · balance_after: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share. The option vests in four equal quarterly installments of Class A Common Stock, beginning on June 27, 2020, until such shares are fully vested; 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| December 03, 2021 Filed Jan 25, 2023 15:17 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-23-000184 · form4.xml · derivative · entry 13 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F13 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Feb 2, 2023 23:23 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-23-000253 · form4.xml · derivative · entry 14 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,973 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F13 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed May 3, 2023 22:45 UTC | SECURITY NATIONAL FINANCIAL CORP SNFC · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-23-000968 · primary_doc.xml · derivative · entry 13 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,973 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F11 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Jun 21, 2023 15:15 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-23-001332 · form4.xml · derivative · entry 12 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F11 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Jul 5, 2023 20:56 UTC | SECURITY NATIONAL FINANCIAL CORP SNFC · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-23-001374 · primary_doc.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Oct 4, 2023 20:49 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-23-001894 · form4.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Dec 4, 2023 23:38 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-23-002322 · form4.xml · derivative · entry 7 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F8 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Dec 12, 2023 19:48 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-23-002350 · form4.xml · derivative · entry 8 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Jan 3, 2024 22:53 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-24-000010 · form4.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Jan 3, 2024 22:09 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-24-000009 · form4.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Mar 12, 2024 14:37 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-24-000406 · form4.xml · derivative · entry 13 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,973 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F11 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Apr 4, 2024 20:26 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-24-000730 · form4.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Jul 2, 2024 22:32 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,300 | $8.19 Strike: $8.19 | $51,597.00 |
DisclosureSEC source: 0001096906-24-001477 · form4.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Class A Common Stock · 6,300 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022. Read SEC document |
| December 03, 2021 Filed Oct 3, 2024 22:46 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,946 | $7.39 Strike: $7.39 | $51,330.94 |
DisclosureSEC source: 0001096906-24-001956 · form4.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,045 Underlying: Class A Common Stock · 6,946 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 08, 2022, July 14, 2023 and July 12, 2024. Read SEC document |
| December 03, 2021 Filed Dec 10, 2024 16:02 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,946 | $7.39 Strike: $7.39 | $51,330.94 |
DisclosureSEC source: 0001096906-24-002242 · form4.xml · derivative · entry 7 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,045 Underlying: Class A Common Stock · 6,946 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023 and July 12, 2024. Read SEC document |
| December 03, 2021 Filed Jan 3, 2025 15:36 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,946 | $7.39 Strike: $7.39 | $51,330.94 |
DisclosureSEC source: 0001096906-25-000006 · form4.xml · derivative · entry 9 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,045 Underlying: Class A Common Stock · 6,946 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023 and July 12, 2024. Read SEC document |
| December 03, 2021 Filed Jan 16, 2025 17:23 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | GrantDirector Stock Option (right to buy) · Derivative | 6,946 | $7.39 Strike: $7.39 | $51,330.94 |
DisclosureSEC source: 0001096906-25-000048 · form4.xml · derivative · entry 14 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,946 shares Expires 2031-12-03 F7 · derivative.exercise_price: This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023 and July 12, 2024. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 18:25 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 312 | $98.40 | $30,700.08 |
DisclosureSEC source: 0001179110-21-009750 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 27, 2021 Filed Oct 29, 2021 21:13 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Unit · Derivative | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-009720 · edgar.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624 Underlying: Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022. Read SEC document |
| October 27, 2021 Filed Oct 29, 2021 21:13 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009720 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:44 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 312 | $96.52 | $30,114.24 |
DisclosureSEC source: 0001179110-21-008036 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 16:48 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007762 · edgar.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936 Underlying: Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock F2 · derivative.exercise_date: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022 F2 · derivative.expiration_date: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022 Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 16:48 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-007762 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock Read SEC document |
| July 16, 2021 Filed Oct 14, 2021 18:10 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | OtherClass A Common Stock | 55 | $8.29 | $455.95 |
DisclosureSEC source: 0001493152-21-025400 · ownership.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164 F1 · kind: Received pursuant to a stock dividend paid on July 16, 2021. Read SEC document |
| May 05, 2021 Filed May 6, 2021 21:33 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 426 | $93.08 | $39,650.55 |
DisclosureSEC source: 0001179110-21-004962 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| April 28, 2021 Filed Apr 28, 2021 23:24 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Unit · Derivative | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004658 · edgar.xml · derivative · entry 3 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,248 Underlying: Common Stock · 426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021. F3 · derivative.expiration_date: Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021. Read SEC document |
| April 28, 2021 Filed Apr 28, 2021 23:24 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-004658 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| April 26, 2021 Filed Apr 28, 2021 23:24 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Unit · Derivative | 1,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004658 · edgar.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,674 Underlying: Common Stock · 1,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022. Read SEC document |
| February 16, 2021 Filed Feb 16, 2021 22:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 426 | $91.54 | $38,995.10 |
DisclosureSEC source: 0001179110-21-001712 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Weighted average price $91.5378. Price range in multiple transactions was $91.505 to $91.61 inclusively. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Unit · Derivative | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001636 · edgar.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426 Underlying: Common Stock · 426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-001636 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 22:14 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 426 | $83.87 | $35,728.24 |
DisclosureSEC source: 0001179110-20-010698 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 23:53 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Unit · Derivative | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-010666 · edgar.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 Underlying: Common Stock · 426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 23:53 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-010666 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 22:44 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | Exercise / conversionClass A Common Stock | 387 | $6.46 | $2,500.02 |
DisclosureSEC source: 0001445866-20-001512 · form4.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2020 Filed Jul 29, 2020 22:58 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 426 | $81.00 | $34,506.00 |
DisclosureSEC source: 0001179110-20-008555 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 22, 2020 Filed Jul 28, 2020 14:58 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Unit · Derivative | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008503 · edgar.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278 Underlying: Common Stock · 426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021. Read SEC document |
| July 22, 2020 Filed Jul 28, 2020 14:58 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-008503 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| July 17, 2020 Filed Jul 23, 2020 20:15 UTC | SECURITY NATIONAL FINANCIAL CORP SNFCA · Entity 6207 | OtherClass A Common Stock | 17 | $5.72 | $97.24 |
DisclosureSEC source: 0001445866-20-001037 · primary_doc.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687 F1 · kind: Received pursuant to a stock dividend paid on July 17, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.